Tuesday, November 13, 2012
FDA Finds Problems At Ameridose
Federal health inspectors found numerous potential sources of contamination at a drug-making facility that has the same founders as the specialty pharmacy linked to a deadly meningitis outbreak. They include including leaky ceilings and insects. The Food and Drug Administration released the results of a monthlong inspection of Ameridose.